Description

Book Synopsis
This book presents original research results on the leading edge of cancer. Topics discussed include one woman''s experience with the Gerson therapy for cancer; epigenetic upregulation or direct over-expression of miR-137 enhances anti-tumour activity of delphinidin for inducing apoptosis in human glioblastoma T98G cells; potentials and challenges of chip technologies in serum biomarker studies for personalised medicine of colorectal cancer; colon cancer; targeting hallmarks of cancer as current therapeutic strategy; and epigenetic regulation of cancer.

Horizons in Cancer Research: Volume 53

Product form

£146.24

Includes FREE delivery

RRP £194.99 – you save £48.75 (25%)

Order before 4pm tomorrow for delivery by Thu 1 Jan 2026.

A Hardback by Hiroto S Watanabe

2 in stock


    View other formats and editions of Horizons in Cancer Research: Volume 53 by Hiroto S Watanabe

    Publisher: Nova Science Publishers Inc
    Publication Date: 01/06/2014
    ISBN13: 9781631172465, 978-1631172465
    ISBN10: 1631172468
    Also in:
    Oncology

    Description

    Book Synopsis
    This book presents original research results on the leading edge of cancer. Topics discussed include one woman''s experience with the Gerson therapy for cancer; epigenetic upregulation or direct over-expression of miR-137 enhances anti-tumour activity of delphinidin for inducing apoptosis in human glioblastoma T98G cells; potentials and challenges of chip technologies in serum biomarker studies for personalised medicine of colorectal cancer; colon cancer; targeting hallmarks of cancer as current therapeutic strategy; and epigenetic regulation of cancer.

    Recently viewed products

    © 2025 Book Curl

      • American Express
      • Apple Pay
      • Diners Club
      • Discover
      • Google Pay
      • Maestro
      • Mastercard
      • PayPal
      • Shop Pay
      • Union Pay
      • Visa

      Login

      Forgot your password?

      Don't have an account yet?
      Create account